Anika Therapeutics, Inc. (ANIK) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 29.61M | 30.61M | 27.82M | 28.22M | 26.17M | -1.29M | 38.75M | 30.72M | 40.52M | 42.97M | 41.47M | 44.3M |
| Revenue Growth % | 13.16% | 2473.26% | -28.22% | -8.15% | -35.42% | -103% | -6.54% | -30.65% | 6.85% | 8.45% | 2.98% | 11.71% |
| Cost of Goods Sold | 10.62M | 11.44M | 12.23M | 13.86M | 11.49M | -23.86M | 37.31M | 10.23M | 15.89M | 16.64M | 16.52M | 15.33M |
| COGS % of Revenue | 35.85% | 37.35% | 43.98% | 49.1% | 43.9% | 1849.22% | 96.28% | 33.31% | 39.22% | 38.73% | 39.84% | 34.6% |
| Gross Profit | 19M | 19.18M | 15.58M | 14.36M | 14.68M | 22.57M | 1.44M | 20.49M | 24.63M | 26.33M | 24.94M | 28.97M |
| Gross Margin % | 64.15% | 62.65% | 56.02% | 50.9% | 56.1% | -1749.22% | 3.72% | 66.69% | 60.78% | 61.27% | 60.16% | 65.4% |
| Gross Profit Growth % | 29.4% | -15.01% | 982.22% | -29.9% | -40.39% | -14.3% | -94.23% | -29.28% | 7.81% | 9.11% | 9.5% | 16.53% |
| Operating Expenses | 24.48M | 18.53M | 18.82M | 18.54M | 18.96M | -5.25M | 29.46M | 22.3M | 29.69M | 90.11M | 32.62M | 32.6M |
| OpEx % of Revenue | 82.69% | 60.54% | 67.65% | 65.71% | 72.47% | 407.21% | 76.01% | 72.58% | 73.27% | 209.7% | 78.66% | 73.59% |
| Selling, General & Admin | 17.77M | 12.08M | 11.87M | 12.23M | 12.91M | -4.89M | 19.11M | 15.62M | 21.53M | 20.34M | 24.83M | 23.69M |
| SG&A % of Revenue | 60.02% | 39.46% | 42.68% | 43.34% | 49.32% | 379.07% | 49.32% | 50.83% | 53.12% | 47.32% | 59.87% | 53.47% |
| Research & Development | 6.71M | 6.45M | 6.95M | 6.31M | 6.06M | 2.74M | 7.24M | 6.68M | 8.16M | 7.58M | 7.79M | 8.91M |
| R&D % of Revenue | 22.67% | 21.07% | 24.97% | 22.37% | 23.15% | -212.25% | 18.69% | 21.75% | 20.15% | 17.65% | 18.79% | 20.12% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -1000K | 1000K | 0 | 0 | 1000K | 0 | 0 |
| Operating Income | -5.49M | 646K | -3.23M | -4.18M | -4.28M | 27.82M | -28.02M | -1.81M | -5.06M | -63.78M | -7.67M | -3.63M |
| Operating Margin % | -18.53% | 2.11% | -11.62% | -14.81% | -16.37% | -2156.43% | -72.3% | -5.89% | -12.49% | -148.43% | -18.51% | -8.2% |
| Operating Income Growth % | -28.1% | -97.68% | 88.46% | -130.94% | 15.39% | 143.61% | -265.09% | 50.15% | 59.67% | -856.67% | -32.36% | -7.39% |
| EBITDA | -4.08M | 1.96M | -1.83M | -2.68M | -2.69M | 29.63M | -25.83M | 248K | -2.46M | -60.21M | -4.13M | -81K |
| EBITDA Margin % | -13.78% | 6.42% | -6.59% | -9.5% | -10.29% | -2296.9% | -66.65% | 0.81% | -6.08% | -140.11% | -9.96% | -0.18% |
| EBITDA Growth % | -51.6% | -93.37% | 92.9% | -1180.64% | -9.25% | 149.21% | -525.1% | 406.17% | 72.63% | -1906.23% | -79.42% | -124.7% |
| D&A (Non-Cash Add-back) | 1.41M | 1.32M | 1.4M | 1.5M | 1.59M | 1.81M | 2.19M | 2.06M | 2.6M | 3.57M | 3.54M | 3.55M |
| EBIT | -5.49M | 646K | -3.23M | -4.18M | -4.28M | 24.72M | -27.61M | -1.81M | -4.47M | -1.59M | -7.67M | -3.63M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 406K | 595K | 0 | 577K | 635K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 406K | 595K | - | 577K | 635K | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Other Income/Expense | 667K | 118K | 997K | 214K | 415K | 744K | 406K | 595K | 592K | 577K | 635K | 561K |
| Pretax Income | -4.82M | 764K | -2.24M | -3.97M | -3.87M | 28.56M | -27.61M | -1.22M | -4.47M | -63.2M | -7.04M | -3.07M |
| Pretax Margin % | -16.28% | 2.5% | -8.04% | -14.05% | -14.79% | -2214.11% | -71.25% | -3.95% | -11.03% | -147.09% | -16.98% | -6.93% |
| Income Tax | 235K | -1.04M | 939K | 681K | 89K | 2.87M | 2.31M | 1.33M | 43K | -204K | -463K | -329K |
| Effective Tax Rate % | -4.87% | -135.73% | -41.99% | -17.17% | -2.3% | 10.05% | -8.36% | -109.14% | -0.96% | 0.32% | 6.58% | 10.72% |
| Net Income | -5.06M | 292K | -2.33M | -3.97M | -4.87M | -21.86M | -29.92M | -88K | -4.51M | -63M | -6.58M | -2.74M |
| Net Margin % | -17.07% | 0.95% | -8.37% | -14.07% | -18.62% | 1694.96% | -77.2% | -0.29% | -11.14% | -146.61% | -15.86% | -6.19% |
| Net Income Growth % | -3.76% | 101.34% | 92.22% | -4411.36% | -7.95% | 65.29% | -354.96% | 96.79% | 56.39% | -1183.62% | -57.51% | 3.59% |
| Net Income (Continuing) | -5.06M | 1.8M | -3.17M | -4.65M | -3.96M | 25.69M | -29.92M | -2.54M | -4.51M | -63M | -6.58M | -2.74M |
| Discontinued Operations | 0 | -1000K | 846K | 677K | -915K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 | -4.30 | -0.45 | -0.19 |
| EPS Growth % | -8.82% | 101.33% | 92.12% | - | -9.68% | 65.12% | -351.11% | 96.89% | 56.34% | -1164.71% | -55.17% | 5% |
| EPS (Basic) | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 | -4.30 | -0.45 | -0.19 |
| Diluted Shares Outstanding | 13.53M | 14.67M | 14.42M | 14.36M | 14.3M | 14.72M | 14.77M | 14.84M | 14.7M | 14.65M | 14.63M | 14.69M |
| Basic Shares Outstanding | 13.53M | 14.27M | 14.42M | 14.36M | 14.3M | 14.58M | 14.77M | 14.84M | 14.7M | 14.65M | 14.63M | 14.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |